The U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) recently discussed nonacog beta pegol, a new treatment for hemophilia B, Novo Nordisk said in release.
CVS Health is launching a prescription savings program with Novo Nordisk that will offer discounts on certain medications.
Novo Nordisk recently broke ground on its new diabetes medicine production facility that is located in Clayton, North Carolina, where locals anticipate the estimated 700 jobs they hope the facility will generate.
Novo Nordisk recently announced positive results from its LEADER trial, which focused on Victoza (Liraglutide injection) and its cardiovascular safety.
Denmark-based Novo Nordisk will invest $2 billion over the next five years to establish new production facilities in Clayton, North Carolina, and in Denmark.